FDA Announces Public Advisory Committee Meeting for Drug Safety and Risk Management

Summary

The FDA is hosting a joint meeting of its Drug Safety and Risk Management Advisory Committee and the Dermatologic and Ophthalmic Drugs Advisory Committee, inviting public input on regulatory issues and establishing a public docket for comments.